Biodefense implications of new-world hantaviruses
dc.contributor.author | D'Souza, Michael H. | |
dc.contributor.author | Patel, Trushar R. | |
dc.date.accessioned | 2023-02-08T22:00:46Z | |
dc.date.available | 2023-02-08T22:00:46Z | |
dc.date.issued | 2020 | |
dc.description | Open access article. Creative Commons Attribution 4.0 International License (CC BY 4.0) applies | en_US |
dc.description.abstract | Hantaviruses, part of the Bunyaviridae family, are a genus of negative-sense, single-stranded RNA viruses that cause two major diseases: New-World Hantavirus Cardiopulmonary Syndrome and Old-World Hemorrhagic Fever with Renal Syndrome. Hantaviruses generally are found worldwide with each disease corresponding to their respective hemispheres. New-World Hantaviruses spread by specific rodent-host reservoirs and are categorized as emerging viruses that pose a threat to global health and security due to their high mortality rate and ease of transmission. Incidentally, reports of Hantavirus categorization as a bioweapon are often contradicted as both US National Institute of Allergy and Infectious Diseases and the Centers for Disease Control and Prevention refer to them as Category A and C bioagents respectively, each retaining qualitative levels of importance and severity. Concerns of Hantavirus being engineered into a novel bioagent has been thwarted by Hantaviruses being difficult to culture, isolate, and purify limiting its ability to be weaponized. However, the natural properties of Hantaviruses pose a threat that can be exploited by conventional and unconventional forces. This review seeks to clarify the categorization of Hantaviruses as a bioweapon, whilst defining the practicality of employing New-World Hantaviruses and their effect on armies, infrastructure, and civilian targets. | en_US |
dc.identifier.citation | D'Souza, M. H., & Patel, T. R. (2020). Biodefense implications of new-world hantaviruses. Frontiers in Bioengineering and Biotechnology, 8, 925, https://doi.org/10.3389/fbioe.2020.00925 | en_US |
dc.identifier.uri | https://hdl.handle.net/10133/6429 | |
dc.language.iso | en_CA | en_US |
dc.publisher | Frontiers Media | en_US |
dc.publisher.department | Department of Chemistry and Biochemistry | |
dc.publisher.faculty | Arts and Science | |
dc.publisher.institution | University of Lethbridge | |
dc.publisher.institution | University of Calgary | |
dc.publisher.institution | University of Alberta | |
dc.publisher.url | https://doi.org/10.3389/fbioe.2020.00925 | |
dc.subject | Hantavirus | en_US |
dc.subject | Sin Nombre Virus | en_US |
dc.subject | Andes Virus | en_US |
dc.subject | Biodefense | en_US |
dc.subject | Viral pandemic | en_US |
dc.subject | Hantavirus cardiopulmonary syndrome | en_US |
dc.subject | Transmission | en_US |
dc.subject.lcsh | Hantavirus--Infections | |
dc.subject.lcsh | Hantavirus pulmonary syndrome | |
dc.subject.lcsh | Hantaviruses | |
dc.subject.lcsh | Bioterrorism | |
dc.title | Biodefense implications of new-world hantaviruses | en_US |
dc.type | Article | en_US |